Quarterly Result31 Jul 2025, 06:32 pm
Indegene Achieves 1.8% QoQ Revenue Growth (USD), Unlocks Revenue Potential from Tectonic
AI Summary
Indegene, a digital-first life sciences commercialization company, announced its financial results for the quarter ended June 30, 2025. The company achieved a revenue of $88.9 million, reflecting 1.8% growth QoQ (USD). Indegene also maintained a strong and stable profitability profile, with an EBITDA margin of 20.2% and a PAT margin of 15.3%. The company's strategic initiative, Tectonic, has unlocked revenue potential by moving upstream along the marketing value chain in the commercial content creation space. Indegene continues to be recognized in the industry for its strategic vision, deep medical and healthcare expertise, advanced technology capabilities, and a robust partner network.
Key Highlights
- Achieved revenue of $88.9 million, reflecting 1.8% growth QoQ (USD)
- Maintained a strong and stable profitability profile, with an EBITDA margin of 20.2% and a PAT margin of 15.3%
- Unlocks revenue potential from its strategic initiative ‘Tectonic’
- Indegene continues to be recognized in the industry for its strategic vision, deep medical and healthcare expertise, advanced technology capabilities and a robust partner network
- Named a Leader in Life Sciences Al and Analytics Services for Commercial PEAK Matrix® Assessment 2025 by Everest Group